Position in MRK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,265,725
+$77,140 QoQ
Shares Held
9,850
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,927
of 3,769 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Continuum Advisory, LLC holds $15,181,531 across 16 Drug Manufacturers - General names. MRK ranks #3 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,744 | $5,690,096 | |
| 2 | ABBV |
AbbVie Inc.
|
13,684 | $3,443,441 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
9,850 | $1,265,725 | |
| 4 | AMGN |
Amgen Inc
|
3,476 | $1,258,729 | |
| 5 | JNJ |
Johnson & Johnson
|
4,515 | $1,146,674 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,971 | $754,376 | |
| 7 | PFE |
Pfizer Inc
|
21,218 | $510,929 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,810 | $334,772 |
All Filings in MRK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,265,725 | 9,850 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,188,585 | 9,881 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $955,129 | 9,074 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $665,480 | 7,929 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $617,606 | 7,802 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $694,742 | 7,740 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $803,897 | 8,081 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $984,678 | 8,671 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,036,453 | 8,372 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,105,872 | 8,381 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,220,696 | 11,197 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,357,498 | 13,186 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,709,041 | 14,811 | Shares | Sole | 2023-12-13 | |
| 2023-03-31 | $3,376,286 | 31,735 | Shares | Sole | 2023-12-13 | |
| 2022-12-31 | $3,530,983 | 31,825 | Shares | Sole | 2023-12-13 | |
| 2022-09-30 | $2,842,821 | 33,010 | Shares | Sole | 2023-12-13 | |
| 2022-06-30 | $2,728,171 | 29,924 | Shares | Sole | 2023-12-13 | |
| 2022-03-31 | $2,003,743 | 24,421 | Shares | Sole | 2023-12-13 | |
| 2021-12-31 | $633,276 | 8,263 | Shares | Sole | 2023-12-13 | |
| 2021-09-30 | $495,951 | 6,603 | Shares | Sole | 2023-12-13 | |
| 2021-06-30 | $471,441 | 6,062 | Shares | Sole | 2023-12-13 | |
| No filing history on record for this holder in this stock. | ||||||